SpliceBio Appoints Leading Ophthalmology Expert Aniz Girach as Chief Medical Officer
- Dr. Girach is a world-renowned specialist in the field of ophthalmology and gene therapy
- Appointment further strengthens SpliceBio’s leadership team as it accelerates lead program targeting Stargardt disease towards clinical development
- Revolutionizing genetic medicine with its proprietary Protein Splicing platform
BARCELONA, January 3rd, 2024 – SpliceBio, a genetic medicines company harnessing Protein Splicing to develop the next generation of gene therapies, is pleased to announce the appointment of Aniz Girach, MD as Chief Medical Officer.
